Doris Benbrook to Bevacizumab
This is a "connection" page, showing publications Doris Benbrook has written about Bevacizumab.
Connection Strength
0.028
-
Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. Gynecol Oncol. 2014 Apr; 133(1):11-5.
Score: 0.028